Literature DB >> 810612

Mucolipidosis III (pseudo-Hurler polydystrophy): Clinical and laboratory studies in a series of 12 patients.

T E Kelly, G H Thomas, H A Taylor, V A McKusick, W S Sly, J H Glaser, M Robinow, L Luzzatti, C Espiritu, M Feingold, M J Bull, E M Ashenhurst, E J Ives.   

Abstract

Mucolipidosis III (pseudo-Hurler polydystrophy) is an autosomal recessively inherited Hurler-like disorder without mucopolysacchariduria. Previous reports have noted a constellation of laboratory features similar to that described for mucolipidosis II (I-cell disease). Studies were carried out on a series of 15 patients. Twelve were found to have changes in serum and cultured fibroblasts which consisted of marked elevations of several acid hydrolases in serum with low levels of the same enzymes in cultured cells, a marked increase in dense cytoplasmic inclusions and abnormal radioactive sulfate kinetics. The clinical features of these 12 patients comprise a phenotypic entity. Despite clinical similarity, the 3 remaining patients were not felt to represent mucolipidosis III. The basic defect in mucolipidosis III remains unknown, but is suggested that the defect is similar to that of mucolipidosis II, from which it must be distinguished clinically.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 810612

Source DB:  PubMed          Journal:  Johns Hopkins Med J        ISSN: 0021-7263


  20 in total

1.  The missing link in lysosomal enzyme targeting.

Authors:  W S Sly
Journal:  J Clin Invest       Date:  2000-03       Impact factor: 14.808

2.  The natural history and osteodystrophy of mucolipidosis types II and III.

Authors:  Grace David-Vizcarra; Julie Briody; Jenny Ault; Michael Fietz; Janice Fletcher; Ravi Savarirayan; Meredith Wilson; Jim McGill; Matthew Edwards; Craig Munns; Melanie Alcausin; Sara Cathey; David Sillence
Journal:  J Paediatr Child Health       Date:  2010-03-29       Impact factor: 1.954

3.  Enlarged follicles and temporomandibular joint abnormalities in mucolipidosis Type III.

Authors:  H Khalifa; H S Grubisa; L Lee; E W N Lam
Journal:  Dentomaxillofac Radiol       Date:  2012-01-12       Impact factor: 2.419

4.  A variant of mucolipidosis. II. Clinical, biochemical and pathological investigations.

Authors:  L Poenaru; L Castelnau; F Tome; J Boue; P Maroteaux
Journal:  Eur J Pediatr       Date:  1988-04       Impact factor: 3.183

5.  Five related Lebanese individuals with high plasma lysosomal hydrolases: a new defect in mannose-6-phosphate receptor recognition?

Authors:  D Alexander; G Dudin; F Talj; F Bitar; M Deeb; A Khudr; M Abboud; V M Der Kaloustian
Journal:  Am J Hum Genet       Date:  1984-09       Impact factor: 11.025

6.  Molecular basis of variant pseudo-hurler polydystrophy (mucolipidosis IIIC)

Authors:  A Raas-Rothschild; V Cormier-Daire; M Bao; E Genin; R Salomon; K Brewer; M Zeigler; H Mandel; S Toth; B Roe; A Munnich; W M Canfield
Journal:  J Clin Invest       Date:  2000-03       Impact factor: 14.808

7.  Identification of a variant of mucolipidosis III (pseudo-Hurler polydystrophy): a catalytically active N-acetylglucosaminylphosphotransferase that fails to phosphorylate lysosomal enzymes.

Authors:  A P Varki; M L Reitman; S Kornfeld
Journal:  Proc Natl Acad Sci U S A       Date:  1981-12       Impact factor: 11.205

8.  Two clonal cell populations (mosaicism) in a 46,XY male with mucolipidosis II (I-cell disease)--an autosomal recessive disorder.

Authors:  G H Thomas; C S Miller; K E Toomey; L W Reynolds; M L Reitman; A Varki; A Vannier; K N Rosebaum; W B Bias; B H Schofield
Journal:  Am J Hum Genet       Date:  1982-07       Impact factor: 11.025

9.  Demonstration of the heterozygous state for I-cell disease and pseudo-Hurler polydystrophy by assay of N-acetylglucosaminylphosphotransferase in white blood cells and fibroblasts.

Authors:  A Varki; M L Reitman; A Vannier; S Kornfeld; J H Grubb; W S Sly
Journal:  Am J Hum Genet       Date:  1982-09       Impact factor: 11.025

10.  An atypical form of mucolipidosis III.

Authors:  P Freisinger; J C Padovani; P Maroteaux
Journal:  J Med Genet       Date:  1992-11       Impact factor: 6.318

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.